Abnormal peripheral lymphocyte function in c-abl mutant mice

被引:35
作者
Hardin, JD
Boast, S
Schwartzberg, PL
Lee, G
Alt, FW
Stall, AM
Goff, SP
机构
[1] COLUMBIA UNIV, COLL PHYS & SURG, DEPT MICROBIOL, NEW YORK, NY 10032 USA
[2] COLUMBIA UNIV, COLL PHYS & SURG, HOWARD HUGHES MED INST, NEW YORK, NY 10032 USA
[3] HOWARD HUGHES MED INST, BOSTON, MA 02115 USA
关键词
D O I
10.1006/cimm.1996.0220
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The proto-oncogene c-abl encodes a tyrosine kinase that is hypothesized to function in proliferation-stimulatory signaling pathways. Previous work on mice homozygous for targeted mutations in the c-abl gene (abl(m1) and abl(2) mutant strains) has demonstrated multiple defects, including a susceptibility to infections that results in a high mortality rate after weaning. FAGS analysis of the hemopoietic system of c-abl mutants demonstrated variable reductions in B and T lymphocytes in adult bone marrow, thymus, spleen, and peripheral blood, In addition, bone marrow from mutants showed a decreased ability to respond to interleukin-7. We further found that B cells from abl(ml) mice had a reduced ability to respond to lipopolysaccharide (decreased to 10% of control response) that was dependent on the culture conditions and the tissue of origin of B cells. Peripheral blood from the mutants also had a reduced response to the T cell mitogen concanavalin A, Immune response in abl(m1) mice as determined by the mixed lymphocyte response and the sheep red blood cell plaque-forming assay was grossly normal. These findings suggest that although specific signaling pathways in lymphocytes may involve c-Abl, the immune system can function in the absence of a normal c-abl gene product. (C) 1996 Academic Press, Inc.
引用
收藏
页码:100 / 107
页数:8
相关论文
共 54 条
  • [11] PHILADELPHIA CHROMOSOMAL BREAKPOINTS ARE CLUSTERED WITHIN A LIMITED REGION, BCR, ON CHROMOSOME-22
    GROFFEN, J
    STEPHENSON, JR
    HEISTERKAMP, N
    DEKLEIN, A
    BARTRAM, CR
    GROSVELD, G
    [J]. CELL, 1984, 36 (01) : 93 - 99
  • [12] BONE-MARROW B-LYMPHOCYTE DEVELOPMENT IN C-ABL-DEFICIENT MICE
    HARDIN, JD
    BOAST, S
    SCHWARTZBERG, PL
    LEE, G
    ALT, FW
    STALL, AM
    GOFF, SP
    [J]. CELLULAR IMMUNOLOGY, 1995, 165 (01) : 44 - 54
  • [13] A BCR-V-ABL ONCOGENE INDUCES LYMPHOMAS IN TRANSGENIC MICE
    HARIHARAN, IK
    HARRIS, AW
    CRAWFORD, M
    ABUD, H
    WEBB, E
    CORY, S
    ADAMS, JM
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (07) : 2798 - 2805
  • [14] ACTIVATION AND PROLIFERATION SIGNALS IN MOUSE B-CELLS .1. A COMPARISON OF THE CAPACITY OF ANTI-IG ANTIBODIES OR PHORBOL MYRISTIC ACETATE TO ACTIVATE B-CELLS FROM CBA/N OR NORMAL MICE INTO G1
    HAWRYLOWICZ, CM
    KEELER, KD
    KLAUS, GGB
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1984, 14 (03) : 244 - 250
  • [15] ACUTE-LEUKEMIA IN BCR/ABL TRANSGENIC MICE
    HEISTERKAMP, N
    JENSTER, G
    TENHOEVE, J
    ZOVICH, D
    PATTENGALE, PK
    GROFFEN, J
    [J]. NATURE, 1990, 344 (6263) : 251 - 253
  • [16] HOWARD M, 1986, J IMMUNOL, V136, P4531
  • [17] N-TERMINAL MUTATIONS ACTIVATE THE LEUKEMOGENIC POTENTIAL OF THE MYRISTOYLATED FORM OF C-ABL
    JACKSON, P
    BALTIMORE, D
    [J]. EMBO JOURNAL, 1989, 8 (02) : 449 - 456
  • [18] DEFECTIVE COLONY FORMATION BY B LYMPHOCYTES FROM CBA-N AND C3H-HEJ MICE
    KINCADE, PW
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1977, 145 (02) : 249 - 263
  • [19] KINCADE PW, 1989, ANNU REV IMMUNOL, V7, P111, DOI 10.1146/annurev.iy.07.040189.000551